AI is being used across cancer care for prevention, diagnosis, treatment, survivorship and end-of-life support, improving ...

Cardiac toxicities such as myocarditis are rare but carry a high risk of being fatal. The data emphasize that the most ...

Amanda shares advice on resilience, self-advocacy and finding strength while navigating cancer survivorship and chronic GVHD.

New NCCN guidelines highlight personalized combo treatments and new options to help patients with advanced kidney cancer live ...

Caregiving evolved from quasi-nursing tasks and close monitoring to anticipatory scheduling, fatigue management, and ...

FDA fast tracked ZW191 for platinum-resistant ovarian cancer, aiming to speed development of a potential new option for patients with limited treatments. The U.S. Food and Drug Administration (FDA) ...

Black patients with early-stage lung cancer were less likely to receive curative treatment than White patients, despite all having Medicare coverage, study finds. Dr. Olivia Lynch, a postdoctoral ...

To better predict these risks, the new guidelines recommend that all stage 2 and 3 colorectal tumors undergo molecular ...

FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...

ORR 35.8% overall, 37.5% in second-/third-line, and 47.1% in light/nonsmokers, with median DOR not reached in key subsets.

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, ...

Faith that God was going to use me and my health would improve and motivate me to keep me pushing on my journey and not look ...